Annual CFO
$181.75 M
-$91.31 M-33.44%
31 March 2024
Summary:
Haemonetics annual cash flow from operations is currently $181.75 million, with the most recent change of -$91.31 million (-33.44%) on 31 March 2024. During the last 3 years, it has risen by +$72.95 million (+67.04%). HAE annual CFO is now -33.44% below its all-time high of $273.06 million, reached on 01 March 2023.HAE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$48.82 M
+$76.24 M+278.05%
28 September 2024
Summary:
Haemonetics quarterly cash flow from operations is currently $48.82 million, with the most recent change of +$76.24 million (+278.05%) on 28 September 2024. Over the past year, it has dropped by -$50.30 million (-50.75%). HAE quarterly CFO is now -50.75% below its all-time high of $99.12 million, reached on 30 September 2023.HAE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$84.94 M
-$50.30 M-37.19%
28 September 2024
Summary:
Haemonetics TTM cash flow from operations is currently $84.94 million, with the most recent change of -$50.30 million (-37.19%) on 28 September 2024. Over the past year, it has dropped by -$177.29 million (-67.61%). HAE TTM CFO is now -68.89% below its all-time high of $273.06 million, reached on 01 March 2023.HAE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HAE Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -33.4% | -50.8% | -67.6% |
3 y3 years | +67.0% | -21.8% | -19.7% |
5 y5 years | +14.1% | +63.3% | -23.7% |
HAE Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -33.4% | +67.0% | -50.8% | +278.1% | -68.9% | at low |
5 y | 5 years | -33.4% | +67.0% | -50.8% | +278.1% | -68.9% | at low |
alltime | all time | -33.4% | +1065.1% | -50.8% | +278.1% | -68.9% | +2195.8% |
Haemonetics Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $48.82 M(-278.0%) | $84.94 M(-37.2%) |
June 2024 | - | -$27.42 M(-142.8%) | $135.24 M(-25.6%) |
Mar 2024 | $181.75 M(-33.4%) | - | - |
Mar 2024 | - | $64.08 M(<-9900.0%) | $181.75 M(-7.9%) |
Dec 2023 | - | -$540.00 K(-100.5%) | $197.28 M(-24.8%) |
Sept 2023 | - | $99.12 M(+419.4%) | $262.24 M(+4.8%) |
June 2023 | - | $19.09 M(-76.0%) | $250.15 M(-8.4%) |
Mar 2023 | $273.06 M(+58.5%) | $79.61 M(+23.6%) | $273.06 M(+4.4%) |
Dec 2022 | - | $64.42 M(-26.0%) | $261.50 M(+0.8%) |
Sept 2022 | - | $87.04 M(+107.3%) | $259.51 M(+20.2%) |
June 2022 | - | $41.99 M(-38.3%) | $215.94 M(+25.4%) |
Mar 2022 | $172.26 M(+58.3%) | $68.05 M(+9.0%) | $172.26 M(+62.9%) |
Dec 2021 | - | $62.43 M(+43.7%) | $105.76 M(-3.5%) |
Sept 2021 | - | $43.46 M(-2686.9%) | $109.62 M(+15.0%) |
June 2021 | - | -$1.68 M(-208.6%) | $95.31 M(-12.4%) |
Mar 2021 | $108.81 M(-31.2%) | $1.55 M(-97.7%) | $108.81 M(-29.2%) |
Dec 2020 | - | $66.29 M(+127.4%) | $153.66 M(-7.8%) |
Sept 2020 | - | $29.16 M(+146.8%) | $166.66 M(-0.4%) |
June 2020 | - | $11.81 M(-74.5%) | $167.40 M(+5.8%) |
Mar 2020 | $158.22 M(-0.7%) | $46.41 M(-41.5%) | $158.22 M(+19.5%) |
Dec 2019 | - | $79.28 M(+165.1%) | $132.45 M(+19.0%) |
Sept 2019 | - | $29.90 M(+1037.8%) | $111.33 M(-19.8%) |
June 2019 | - | $2.63 M(-87.3%) | $138.79 M(-12.9%) |
Mar 2019 | $159.28 M(-27.7%) | $20.64 M(-64.5%) | $159.28 M(-18.8%) |
Dec 2018 | - | $58.16 M(+1.4%) | $196.27 M(-3.6%) |
Sept 2018 | - | $57.36 M(+148.1%) | $203.50 M(-0.8%) |
June 2018 | - | $23.12 M(-59.9%) | $205.05 M(-6.9%) |
Mar 2018 | $220.35 M(+37.9%) | $57.63 M(-11.9%) | $220.35 M(+11.7%) |
Dec 2017 | - | $65.39 M(+11.0%) | $197.30 M(+5.4%) |
Sept 2017 | - | $58.90 M(+53.3%) | $187.11 M(+11.7%) |
June 2017 | - | $38.42 M(+11.1%) | $167.47 M(+4.8%) |
Mar 2017 | $159.74 M(+31.1%) | $34.58 M(-37.4%) | $159.74 M(-10.5%) |
Dec 2016 | - | $55.20 M(+40.6%) | $178.41 M(+15.1%) |
Sept 2016 | - | $39.27 M(+27.9%) | $155.06 M(+8.2%) |
June 2016 | - | $30.70 M(-42.4%) | $143.31 M(+17.6%) |
Mar 2016 | $121.86 M(-4.2%) | $53.25 M(+67.2%) | $121.86 M(-1.7%) |
Dec 2015 | - | $31.85 M(+15.8%) | $123.92 M(+4.2%) |
Sept 2015 | - | $27.51 M(+197.4%) | $118.96 M(-3.0%) |
June 2015 | - | $9.25 M(-83.3%) | $122.69 M(-3.5%) |
Mar 2015 | $127.18 M(-8.8%) | $55.30 M(+105.6%) | $127.18 M(+3.1%) |
Dec 2014 | - | $26.89 M(-13.9%) | $123.34 M(-13.0%) |
Sept 2014 | - | $31.24 M(+127.4%) | $141.74 M(+1.3%) |
June 2014 | - | $13.74 M(-73.3%) | $139.86 M(+0.2%) |
Mar 2014 | $139.52 M(+64.0%) | $51.47 M(+13.6%) | $139.52 M(+20.7%) |
Dec 2013 | - | $45.29 M(+54.3%) | $115.59 M(+22.6%) |
Sept 2013 | - | $29.36 M(+119.1%) | $94.27 M(-3.7%) |
June 2013 | - | $13.40 M(-51.3%) | $97.92 M(+15.1%) |
Mar 2013 | $85.07 M(-26.2%) | $27.54 M(+14.9%) | $85.07 M(-7.0%) |
Dec 2012 | - | $23.96 M(-27.4%) | $91.51 M(-5.0%) |
Sept 2012 | - | $33.01 M(+5870.0%) | $96.35 M(+8.6%) |
June 2012 | - | $553.00 K(-98.4%) | $88.74 M(-23.0%) |
Mar 2012 | $115.32 M(-6.6%) | $33.98 M(+18.0%) | $115.32 M(+1.6%) |
Dec 2011 | - | $28.80 M(+13.4%) | $113.48 M(-13.8%) |
Sept 2011 | - | $25.41 M(-6.4%) | $131.71 M(-3.9%) |
June 2011 | - | $27.13 M(-15.6%) | $137.06 M(+11.0%) |
Mar 2011 | $123.45 M(-5.5%) | $32.14 M(-31.7%) | $123.45 M(-3.6%) |
Dec 2010 | - | $47.03 M(+52.9%) | $128.00 M(+12.8%) |
Sept 2010 | - | $30.76 M(+127.4%) | $113.47 M(-4.2%) |
June 2010 | - | $13.53 M(-63.1%) | $118.49 M(-9.3%) |
Mar 2010 | $130.67 M(+12.3%) | $36.69 M(+12.9%) | $130.67 M(-5.1%) |
Dec 2009 | - | $32.50 M(-9.1%) | $137.69 M(+1.2%) |
Sept 2009 | - | $35.77 M(+39.2%) | $136.07 M(+6.1%) |
June 2009 | - | $25.71 M(-41.2%) | $128.23 M(+10.2%) |
Mar 2009 | $116.36 M(+49.8%) | $43.71 M(+41.5%) | $116.36 M(+11.3%) |
Dec 2008 | - | $30.88 M(+10.5%) | $104.57 M(+6.1%) |
Sept 2008 | - | $27.93 M(+101.8%) | $98.57 M(+27.5%) |
June 2008 | - | $13.84 M(-56.6%) | $77.33 M(-0.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2008 | $77.67 M(-7.1%) | $31.91 M(+28.3%) | $77.67 M(+11.2%) |
Dec 2007 | - | $24.88 M(+271.4%) | $69.85 M(-1.5%) |
Sept 2007 | - | $6.70 M(-52.8%) | $70.94 M(-11.6%) |
June 2007 | - | $14.18 M(-41.1%) | $80.23 M(-4.0%) |
Mar 2007 | $83.56 M(-2.4%) | $24.10 M(-7.2%) | $83.56 M(-2.4%) |
Dec 2006 | - | $25.97 M(+62.4%) | $85.59 M(-11.3%) |
Sept 2006 | - | $15.99 M(-8.7%) | $96.49 M(+5.6%) |
June 2006 | - | $17.51 M(-33.0%) | $91.37 M(+6.7%) |
Mar 2006 | $85.62 M(+20.2%) | $26.12 M(-29.1%) | $85.62 M(+4.1%) |
Dec 2005 | - | $36.87 M(+239.2%) | $82.24 M(+23.8%) |
Sept 2005 | - | $10.87 M(-7.6%) | $66.45 M(-9.6%) |
June 2005 | - | $11.76 M(-48.3%) | $73.51 M(+3.2%) |
Mar 2005 | $71.21 M(-7.2%) | $22.74 M(+7.9%) | $71.21 M(-8.1%) |
Dec 2004 | - | $21.08 M(+17.6%) | $77.48 M(-5.3%) |
Sept 2004 | - | $17.93 M(+89.5%) | $81.84 M(-2.2%) |
June 2004 | - | $9.46 M(-67.4%) | $83.67 M(+9.0%) |
Mar 2004 | $76.77 M(+63.4%) | $29.02 M(+14.1%) | $76.77 M(+17.4%) |
Dec 2003 | - | $25.44 M(+28.8%) | $65.41 M(+14.3%) |
Sept 2003 | - | $19.75 M(+670.6%) | $57.23 M(+18.6%) |
June 2003 | - | $2.56 M(-85.5%) | $48.27 M(+2.8%) |
Mar 2003 | $46.98 M(+41.0%) | $17.65 M(+2.2%) | $46.98 M(-1.1%) |
Dec 2002 | - | $17.27 M(+60.1%) | $47.51 M(+61.8%) |
Sept 2002 | - | $10.79 M(+750.9%) | $29.36 M(-11.2%) |
June 2002 | - | $1.27 M(-93.0%) | $33.07 M(-0.7%) |
Mar 2002 | $33.31 M(-41.4%) | $18.19 M(-2155.3%) | $33.31 M(-11.8%) |
Dec 2001 | - | -$885.00 K(-106.1%) | $37.77 M(-21.6%) |
Sept 2001 | - | $14.49 M(+858.0%) | $48.15 M(-10.6%) |
June 2001 | - | $1.51 M(-93.3%) | $53.88 M(-5.2%) |
Mar 2001 | $56.82 M(+6.3%) | $22.65 M(+138.5%) | $56.82 M(-3.6%) |
Dec 2000 | - | $9.49 M(-53.1%) | $58.93 M(+17.8%) |
Sept 2000 | - | $20.22 M(+354.5%) | $50.04 M(-1.5%) |
June 2000 | - | $4.45 M(-82.0%) | $50.81 M(-5.0%) |
Mar 2000 | $53.47 M(+58.6%) | $24.77 M(+4027.5%) | $53.47 M(+11.1%) |
Dec 1999 | - | $600.00 K(-97.1%) | $48.11 M(+7.8%) |
Sept 1999 | - | $21.00 M(+195.8%) | $44.61 M(+49.1%) |
June 1999 | - | $7.10 M(-63.4%) | $29.91 M(-11.3%) |
Mar 1999 | $33.71 M(+65.3%) | $19.41 M(-769.4%) | $33.71 M(-17.6%) |
Dec 1998 | - | -$2.90 M(-146.0%) | $40.90 M(-18.4%) |
Sept 1998 | - | $6.30 M(-42.2%) | $50.10 M(+32.9%) |
June 1998 | - | $10.90 M(-59.0%) | $37.70 M(+84.8%) |
Mar 1998 | $20.40 M(-56.5%) | $26.60 M(+322.2%) | $20.40 M(+36.0%) |
Dec 1997 | - | $6.30 M(-203.3%) | $15.00 M(-41.4%) |
Sept 1997 | - | -$6.10 M(-4.7%) | $25.60 M(-35.0%) |
June 1997 | - | -$6.40 M(-130.2%) | $39.40 M(-16.0%) |
Mar 1997 | $46.90 M(-14.4%) | $21.20 M(+25.4%) | $46.90 M(+34.0%) |
Dec 1996 | - | $16.90 M(+119.5%) | $35.00 M(-8.9%) |
Sept 1996 | - | $7.70 M(+600.0%) | $38.40 M(-21.1%) |
June 1996 | - | $1.10 M(-88.2%) | $48.70 M(-11.1%) |
Mar 1996 | $54.80 M(+251.3%) | $9.30 M(-54.2%) | $54.80 M(+2.8%) |
Dec 1995 | - | $20.30 M(+12.8%) | $53.30 M(+46.8%) |
Sept 1995 | - | $18.00 M(+150.0%) | $36.30 M(+50.0%) |
June 1995 | - | $7.20 M(-7.7%) | $24.20 M(+55.1%) |
Mar 1995 | $15.60 M(-42.2%) | $7.80 M(+136.4%) | $15.60 M(+0.6%) |
Dec 1994 | - | $3.30 M(-44.1%) | $15.50 M(-34.6%) |
Sept 1994 | - | $5.90 M(-521.4%) | $23.70 M(-1.3%) |
June 1994 | - | -$1.40 M(-118.2%) | $24.00 M(-11.1%) |
Mar 1994 | $27.00 M(-24.8%) | $7.70 M(-33.0%) | $27.00 M(-3.9%) |
Dec 1993 | - | $11.50 M(+85.5%) | $28.10 M(-7.9%) |
Sept 1993 | - | $6.20 M(+287.5%) | $30.50 M(-13.1%) |
June 1993 | - | $1.60 M(-81.8%) | $35.10 M(-2.2%) |
Mar 1993 | $35.90 M(+91.0%) | $8.80 M(-36.7%) | $35.90 M(-14.9%) |
Dec 1992 | - | $13.90 M(+28.7%) | $42.20 M(+73.7%) |
Sept 1992 | - | $10.80 M(+350.0%) | $24.30 M(+60.9%) |
June 1992 | - | $2.40 M(-84.1%) | $15.10 M(-19.7%) |
Mar 1992 | $18.80 M | $15.10 M(-477.5%) | $18.80 M(+408.1%) |
Dec 1991 | - | -$4.00 M(-350.0%) | $3.70 M(-51.9%) |
Sept 1991 | - | $1.60 M(-73.8%) | $7.70 M(+26.2%) |
June 1991 | - | $6.10 M | $6.10 M |
FAQ
- What is Haemonetics annual cash flow from operations?
- What is the all time high annual CFO for Haemonetics?
- What is Haemonetics annual CFO year-on-year change?
- What is Haemonetics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Haemonetics?
- What is Haemonetics quarterly CFO year-on-year change?
- What is Haemonetics TTM cash flow from operations?
- What is the all time high TTM CFO for Haemonetics?
- What is Haemonetics TTM CFO year-on-year change?
What is Haemonetics annual cash flow from operations?
The current annual CFO of HAE is $181.75 M
What is the all time high annual CFO for Haemonetics?
Haemonetics all-time high annual cash flow from operations is $273.06 M
What is Haemonetics annual CFO year-on-year change?
Over the past year, HAE annual cash flow from operations has changed by -$91.31 M (-33.44%)
What is Haemonetics quarterly cash flow from operations?
The current quarterly CFO of HAE is $48.82 M
What is the all time high quarterly CFO for Haemonetics?
Haemonetics all-time high quarterly cash flow from operations is $99.12 M
What is Haemonetics quarterly CFO year-on-year change?
Over the past year, HAE quarterly cash flow from operations has changed by -$50.30 M (-50.75%)
What is Haemonetics TTM cash flow from operations?
The current TTM CFO of HAE is $84.94 M
What is the all time high TTM CFO for Haemonetics?
Haemonetics all-time high TTM cash flow from operations is $273.06 M
What is Haemonetics TTM CFO year-on-year change?
Over the past year, HAE TTM cash flow from operations has changed by -$177.29 M (-67.61%)